Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Opioid Labeling Instructions On Naloxone Are Compromise In Co-Prescribing Debate
Jul 26 2020
•
By
Derrick Gingery
The FDA Drug Safety Communication also recommends prescribing naloxone to patients with children or other household members at risk of accidental ingestion or overdose. • Source: Shutterstock
More from Drug Safety
More from Pink Sheet